[go: up one dir, main page]

HUP0200053A3 - Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same - Google Patents

Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same

Info

Publication number
HUP0200053A3
HUP0200053A3 HU0200053A HUP0200053A HUP0200053A3 HU P0200053 A3 HUP0200053 A3 HU P0200053A3 HU 0200053 A HU0200053 A HU 0200053A HU P0200053 A HUP0200053 A HU P0200053A HU P0200053 A3 HUP0200053 A3 HU P0200053A3
Authority
HU
Hungary
Prior art keywords
nonan
diazabicyclo
cyclopropyl
dihydro
oxo
Prior art date
Application number
HU0200053A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HUP0200053A2 publication Critical patent/HUP0200053A2/hu
Publication of HUP0200053A3 publication Critical patent/HUP0200053A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU0200053A 1999-02-26 2000-02-14 Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same HUP0200053A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19908448A DE19908448A1 (de) 1999-02-26 1999-02-26 Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure

Publications (2)

Publication Number Publication Date
HUP0200053A2 HUP0200053A2 (hu) 2002-05-29
HUP0200053A3 true HUP0200053A3 (en) 2003-01-28

Family

ID=7899026

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200053A HUP0200053A3 (en) 1999-02-26 2000-02-14 Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same

Country Status (22)

Country Link
US (1) US6492391B1 (hu)
EP (1) EP1159277A1 (hu)
JP (1) JP2002538159A (hu)
KR (1) KR100756474B1 (hu)
CN (1) CN1217944C (hu)
AU (1) AU760710B2 (hu)
BR (1) BR0008520A (hu)
CA (1) CA2362804A1 (hu)
CZ (1) CZ20013065A3 (hu)
DE (1) DE19908448A1 (hu)
HK (1) HK1045158B (hu)
HU (1) HUP0200053A3 (hu)
IL (1) IL144528A0 (hu)
NO (1) NO320314B1 (hu)
NZ (1) NZ513749A (hu)
PL (1) PL349394A1 (hu)
RU (1) RU2248357C2 (hu)
SK (1) SK11942001A3 (hu)
TR (1) TR200102435T2 (hu)
UA (1) UA71606C2 (hu)
WO (1) WO2000052010A1 (hu)
ZA (1) ZA200106050B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
PE20191462A1 (es) 2017-02-13 2019-10-16 Bayer Animal Health Gmbh Composicion liquida que contiene pradofloxacina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676521B2 (ja) * 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
MX9703622A (es) * 1994-11-18 1997-08-30 Upjohn Co Una nueva forma solida fisicamente estable en una fluoroquinolona.
AU715341B2 (en) * 1996-02-23 2000-01-20 Bayer Intellectual Property Gmbh Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8- diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo- 3-quinolin carboxylic acids and their derivatives
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
JP2001242582A (ja) * 2000-02-25 2001-09-07 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその現像処理方法

Also Published As

Publication number Publication date
RU2248357C2 (ru) 2005-03-20
NZ513749A (en) 2003-10-31
HUP0200053A2 (hu) 2002-05-29
NO20014059L (no) 2001-08-21
US6492391B1 (en) 2002-12-10
KR20010093300A (ko) 2001-10-27
IL144528A0 (en) 2002-05-23
TR200102435T2 (tr) 2002-01-21
EP1159277A1 (de) 2001-12-05
HK1045158A1 (en) 2002-11-15
AU3154400A (en) 2000-09-21
CN1217944C (zh) 2005-09-07
UA71606C2 (uk) 2004-12-15
ZA200106050B (en) 2002-07-24
NO320314B1 (no) 2005-11-21
HK1045158B (zh) 2006-04-21
NO20014059D0 (no) 2001-08-21
BR0008520A (pt) 2001-12-18
AU760710B2 (en) 2003-05-22
DE19908448A1 (de) 2000-08-31
SK11942001A3 (sk) 2001-12-03
JP2002538159A (ja) 2002-11-12
PL349394A1 (en) 2002-07-15
CZ20013065A3 (cs) 2002-01-16
CN1341116A (zh) 2002-03-20
WO2000052010A1 (de) 2000-09-08
CA2362804A1 (en) 2000-09-08
KR100756474B1 (ko) 2007-09-07

Similar Documents

Publication Publication Date Title
EP1216980A4 (en) CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME
IL107221A0 (en) Carboxylic acid derivatives, pharmaceutical compositions containing them and processes for their preparation
FI104174B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, 1,4-dihydro-4-okso-3-kinoliinikarboksyylihapon 7-[S,S]-2,8-diatsabisyklo[4.3.0]nonaani-isomeeriven valmistamiseksi
IL145732A0 (en) α-SUBSTITUTED CARBOXYLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0200807A3 (en) Substituted propionic acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL119795A0 (en) Crystalline 1-cyclopropyl-7-([S,S]-2,9-diazabicyclo-[4.3.0]non-8-YL) 6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid hydrochloride its preparation and pharmaceutical formulations containing it
HUP0204373A3 (en) Carboxylic acid amides, pharmaceutical compositions containing these compounds and the use and production thereof
HUP0000728A3 (en) Salt of naphthyridine carboxylic acid derivative, process for producing it and pharmaceutical composition containing it
HUP0000450A3 (en) The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases
IL141165A0 (en) New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same
HUP0104713A3 (en) Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions thereof
IL159084A0 (en) Tetrahydroisoquinoline carboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0103788A3 (en) Processes for the preparation of 5-hydroxy-3-oxopentanoic acid derivatives
HUP0200053A3 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical compositions containing the same
HUP0200006A3 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
HUP0104367A3 (en) Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof
ZA932944B (en) Quinolone carboxylic acid derivatives and process for preparing the same
WO2001017961A3 (en) Intermediates for the production of naphthyridine-3-carboxylic acid derivatives
HUP0104465A3 (en) Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid, process for its preparation and pharmaceutical composition thereof
ATE226582T1 (de) Pyrrolo(3,4-b)chinolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
HUP0100957A3 (en) 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same, their use and pharmaceutical compositions containing them
HUP0004916A3 (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2,3-dicarboxylic acid anhydride and (s)-n-terc-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide by using thereof
HUP0000982A3 (en) Process for the preparation of 1,1-dioxo-penicillanic acid derivatives
ZA971507B (en) Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo(4.3.0)nonan-8-YL)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives.